Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.
Start main contents.
 

[Photo] Unwavering commitment

Message from the President

Message from FUJIFILM KYOWA KIRIN BIOLOGICS President Hideaki Nomura.

Outline

Basic corporate data for FUJIFILM KYOWA KIRIN BIOLOGICS.

Business Field

FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. engages in the development, manufacture and marketing of biosimilars.

Location

Locations of our headquarters and facility.


What's New

Feb. 26, 2013
Production & Development Centre opened by Fujifilm Kyowa Kirin Biologics
Oct. 24, 2012
Fujifilm Kyowa Kirin Biologics to initiate development of biosimilar of bevacizumab, an anti-VEGF humanized monoclonal antibody which has impressive therapeutic effects for cancers such as colorectal cancer
Mar. 27, 2012
Establishment of Fujifilm Kyowa Kirin Biologics
Nov. 16, 2011
Fujifilm and Kyowa Hakko Kirin to set up a joint venture for the development of biosimilars

Group Companies

Kyowa Hakko Kirin Co., Ltd.

Fujifilm Global

Contact Us

Contact FUJIFILM KYOWA KIRIN BIOLOGICS

Back to Top
Footer starts here.
Pages ends here.
Move to top of the page.